Codivex
ActiveSummary
Codivex has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €504,105 and a net result of €54,034. Equity is growing by ~10.5% per year across the filed fiscal years. Its solvency ranks better than 95% of 575 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 27 days late
2025
26-09
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 57 days late
2024
31-12
Financial
Liquidity quadruplescurrent ratio 10.25
Current ratio from 2.79 to 10.25; short-term debt falls from €217,276 to €48,678.
31-12
Financial
Equity above €500,000Eq €550,072 ▲11%
5 profitable years in a row build equity to €550,072.
28-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 28 days late
2023
27-09
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 58 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
2021
17-09
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 48 days late
2020
31-12
Financial
Back to profitnet €230,986
Net result €230,986 after 2 loss-making years.
31-12
Financial
Equity above €200,000Eq €356,943 ▲91.9%
Equity rises from €185,957 to €356,943.
11-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 42 days late
2019
27-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
06-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
21-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.